Skip to content

Harrow HROW Branded — Cost of Goods Sold

Other segment segments

Compounding
$6.2M-15.5%

Similar metrics at other companies

Calumet, Inc. logo
CLMTPerformance Brands — Cost of Goods Sold
$66.4M+17.1%
LQD
LQDAProduct — Cost of Goods Sold
$11.08M
Monster Beverage logo
MNSTStrategic Brands — Cost of Goods Sold
$43.57M+42.0%
OSI Systems logo
OSISProduct — Cost of Goods Sold
$242.57M+2.5%
Agilysys logo
AGYSProduct — Cost of Goods Sold
$6.17M+1.5%
Neogen logo
NEOGProduct — Cost of Goods Sold
$96M+0.2%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's branded — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's branded — cost of goods sold?
Harrow (HROW) reported branded — cost of goods sold of $10.95M in Q1 2026.
How has Harrow's branded — cost of goods sold changed year-over-year?
Harrow's branded — cost of goods sold increased by 33.9% year-over-year, from $8.18M to $10.95M.
What does branded — cost of goods sold mean?
This metric captures the direct costs attributable to the production and delivery of branded pharmaceutical products, including raw materials, manufacturing labor, and distribution expenses. Monitoring this helps assess the efficiency of the supply chain and production processes for the branded segment.